Jan 13 (Reuters) - Standard BioTools Inc LAB.O:
STANDARD BIOTOOLS ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2024 REVENUE
EXPECTS Q4 2024 REVENUE OF APPROXIMATELY $46.5 MILLION
EXPECTS FULL YEAR 2024 REVENUE OF APPROXIMATELY $174 MILLION
Source text: ID:nGNXF0yqy
Further company coverage: LAB.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.